as on September 13, 2025 at 1:29 am IST
Day's Low
Day's High
0.63%
Downside
5.28%
Upside
52 Week's Low
52 Week's High
40.70%
Downside
140.14%
Upside
Check Neogenomics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.0B
EPS (TTM)
0.0992
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
1.31%
PE Ratio (TTM)
-26.79
Industry PE ratio
10.127857142857144
P/B Ratio
0PEG Ratio
3.02
EBITDA
-7.8M
Revenue (TTM)
689.2M
Profit Margin
-15.10%
Return On Equity TTM
16253500.00%
Track how Neogenomics, Inc. P/E has moved over time to understand its valuation trends.
Neogenomics, Inc. in the last 5 years
Lowest (0.00x)
September 13, 2025
Today (-26.79x)
September 13, 2025
Industry (10.13x)
September 13, 2025
Highest (0.00x)
September 13, 2025
Today’s Price to Earnings Ratio: -26.79x
Compare market cap, revenue, PE, and other key metrics of Neogenomics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $1.0B | -77.48% | -26.79 | -15.10% |
The Neogenomics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Neogenomics, Inc. investment value today
Current value as on today
₹53,676
Returns
Returns from Neogenomics, Inc. Stock
Dollar Returns*
₹5,139 (+5.14%)
Based on 17 analysts
76.47%
Buy
23.53%
Hold
0.00%
Sell
Based on 17 analysts, 76.47% of analysts recommend a 'BUY' rating for Neogenomics, Inc.. Average target price of $10
Get share price movements and forecasts by analysts on Neogenomics, Inc..
What analysts predicted
20.4%UPSIDE
Target Price
$10
Current Price
$7.96
Analyzed by
17 Analysts
Target
$10.00
Neogenomics, Inc. target price $10, a slight upside of 20.4% compared to current price of $7.96. According to 17 analysts rating.
Investment in Neogenomics, Inc. Shares on INDmoney has dropped by -33.92% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Neogenomics, Inc. Stock has increased by 69% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:69% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, NEO stock has moved up by 27.6%
Revenue Rich
Revenue is up for the last 2 quarters, 168.03M → 181.33M (in $), with an average increase of 7.3% per quarter
Retail Holding Up
Retail Investor have increased holdings from 51.95% to 52.97% in Mar 2025 quarter
Against Peers
In the last 3 years, Idexx Laboratories, Inc. has given 83.0% return, outperforming this stock by 103.6%
Against Peers
In the last 1 year, Idexx Laboratories, Inc. has given 28.1% return, outperforming this stock by 79.6%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 47.03% of holdings in Mar 2025 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 1.02% to 0.00% in Mar 2025 quarter
Profit Down
Netprofit is down for the last 3 quarters, -15.32M → -45.09M (in $), with an average decrease of 71.6% per quarter
Price Dip
In the last 7 days, NEO stock has moved down by -3.0%
Organisation | Neogenomics, Inc. |
Headquarters | 9490 NeoGenomics Way, Fort Myers, FL, United States, 33912 |
Industry | Health Services |
CEO | Mr. Anthony P. Zook |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Kendra Sweeney | Vice President of Investor Relations & Communications |
Mr. Hutan Hashemi J.D. | Chief Compliance Officer |
Mr. Gary Passman | Chief People & Culture Officer |
Ms. Alicia C. Olivo | Executive VP of Business Development, General Counsel & Corporate Secretary |
Mr. Gregory D. Aunan | Senior VP & Chief Accounting Officer |
Mr. Jeffrey S. Sherman M.B.A. | Chief Financial Officer |
Ms. Elizabeth A. Floegel | Chief Digital & Information Officer |
Mr. Kareem M. Saad | Head of Strategy, Business Development & Transformation |
Mr. Anthony P. Zook | CEO & Director |
Mr. Warren Stone | President & COO |
Neogenomics, Inc. share price today is $7.96 as on at the close of the market. Neogenomics, Inc. share today touched a day high of $8.38 and a low of $7.91.
Neogenomics, Inc. share touched a 52 week high of $19.12 on and a 52 week low of $4.72 on . Neogenomics, Inc. stock price today i.e. is closed at $7.96,which is 58.36% down from its 52 week high and 68.64% up from its 52 week low.
Neogenomics, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Neogenomics, Inc. (NEO) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Neogenomics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Neogenomics, Inc. share’s latest price of $7.96 as on September 13, 2025 at 1:29 am IST, you will get 1.2563 shares of Neogenomics, Inc.. Learn more about
fractional shares .
Neogenomics, Inc. stock has given -77.48% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?